1Aseptic processing and sterility assurance
As previously reported in thepreceding observation, production personnel access the aseptic fill line "(mp es) .
Inspection Record
Amneal Pharmaceuticals Private Ltd. — FDA 483 Findings
View the regulator's official source The source document is always the basis for judgement.
Findings
2Equipment and facility
As confirmed by the Assistant General Manager Project & Engineering Department, there are.no Architectural Layouts (As Build) engineering diagrams for the HVAC units in manufacturing facilities.
3Validation and qualification
The Summary Report for Disinfectant Qualification, document number AP-QCM-MIS-43-00, dated.
4Other quality system
Toassist firms inspected in complying with the Acts and regulations enforced by the Food and Drug Administration.
5Environmental monitoring
The Rationale for Environmental Monitoring dated 14 April 2015, establishes that “A well-defined — .
6Environmental monitoring
The Non-viable particle monitoring is cleanrooms.of facility, document riumber AP-QCM-087 describe the frequency ofmonitoring the Unidirectional air flow (UAF) GradeA,” Grade A clean air stations.
About this record
Extracted automatically from the document US FDA published on 2023-02-22. The source is available at the link above.
This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.
Translation and classification are automated and may differ in nuance from the source.
